(Q37142971)

English

Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.

scientific article published on 18 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Europe PubMed Central

Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

multiple sclerosis

0 references

Federica Agosta

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Massimo Filippi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

D Bar-Zohar

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

D Goldstaub

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

18 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

719-727

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

FDA: evidentiary standards for drug development and approval

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI relapses have significant pathologic and clinical implications in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Disease-modifying therapy in MS: a critical review of the literature. Part II: Assessing efficacy and dose-response

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Current approved options for treating patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

The clinico-radiological paradox in multiple sclerosis revisited

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI techniques to monitor MS evolution: the present and the future

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Surrogate endpoints in clinical trials: definition and operational criteria

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN β-1b

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Measuring brain atrophy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes".

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Optimizing the association between disability and biological markers in MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetic resonance spectroscopy in the monitoring of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

The relationship between diffuse axonal damage and fatigue in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

The accuracy of whole brain N-acetylaspartate quantification.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer imaging: practical aspects and clinical applications

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Correlation of volumetric magnetization transfer imaging with clinical data in MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: consensus report of the White Matter Study Group.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1a

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cord.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Diffusion tensor MRI in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Cortical lesions and brain atrophy in MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Evidence for progressive gray matter loss in patients with relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Thalamic Involvement in Multiple Sclerosis: A Diffusion‐Weighted Magnetic Resonance Imaging Study

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Correlates of MS disability assessed in vivo using aggregates of MR quantities.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Imaging spinal cord damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetisation transfer ratio measurement in the cervical spinal cord: a preliminary study in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Associations between cervical cord gray matter damage and disability in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Quantification of cervical cord pathology in primary progressive MS using diffusion tensor MRI.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Voxel-based analysis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Cladribine and progressive MS: Clinical and MRI outcomes of a multicenter controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer imaging to monitor the evolution of MS: A 1-year follow-up study

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

European Study on Intravenous Immunoglobulin in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Diffusion tensor magnetic resonance imaging in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

A composite score to predict short-term disease activity in patients with relapsing-remitting MS

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Identifiers

10.1177/1352458507088102

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37142971&oldid=1379469585"